Are You Ready to Take Toric Lenses to the MAX?

ACUVUE OASYS MAX 1-DAY New Product packs
COMING EARLY JULY 2025

ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM

MAx 1-Day Multifocal for Astigmatism packshot

The FIRST and ONLY daily disposable multifocal toric contact lens1

Delivers crisp, clear vision at all distances and in all lighting conditions, plus exceptional stability and all-day comfort.2

COMING LATE JULY 2025

ACUVUE® OASYS MAX 1-Day for ASTIGMATISM

MAx 1-Day for Astigmatism packshot

Providing exceptional comfort, clarity, and stability for astigmatic patients.*3

Taking Toric Lenses to the MAX

Meet the two newest ACUVUE® OASYS MAX 1-Day products for ASTIGMATISM
ACUVUE Simplifit logo
COMING SUMMER 2025

The ACUVUE® Fitting Calculator

A new all-in-one tool designed to help increase efficiency and accuracy in finding a suitable trial lens fit for your patients.

Today’s patients face increased screen time4

Man and woman looking at a cellphone

... and exposure to multiple sources of blue-violet light 5

Increased digital device use causes less blinking which can lead to discomfort6,7 and blue-violet light scatters more, which may impact visual clarity.5

Technology

Four Powerful ACUVUE® Technologies for MAX

MAX
Image of tearstable technology

TearStable Technology

2x reduced tear evaporation vs. competition#,8,9,10

MAX
Image of Optiblue Light Filtering

OptiBlue Light Filter

60% blue violet light filtering. Highest in the industry.$,+,8,10

MULTIFOCAL
Example of pupil optimized design on eye

PUPIL OPTIMIZED Design

100% of parameters optimized for pupil size variations across age and refraction. 11

Toric
Blink Stabilized Design on lens

BLINK STABILIZED® Design

Four stability zone design is more resistant to gravity, minimizes lower lid interaction, hassle-free insertion with their symmetrical design, and delivers a prism-free optic zone.†,12

Discover more by visiting the MAX 1-Day product pages

Sphere Badge for Max 1-Day

For Spherical patients

ACUVUE® OASYS MAX 1-Day
Astigmatism Badge for Max 1-Day

For Toric patients

ACUVUE® OASYS MAX 1-Day for ASTIGMATISM
Multifocal for Astigmatism Badge for Max 1-Day

For Presbyopic Toric patients

ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM
Multifocal Badge for Max 1-Day

For Presbyopic patients

ACUVUE® OASYS MAX 1-Day MULTIFOCAL
Sphere Badge for Max 1-Day

For Spherical patients

ACUVUE® OASYS MAX 1-Day
Astigmatism Badge for Max 1-Day

For Toric patients

ACUVUE® OASYS MAX 1-Day for ASTIGMATISM
Multifocal for Astigmatism Badge for Max 1-Day

For Presbyopic Toric patients

ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM
Multifocal Badge for Max 1-Day

For Presbyopic patients

ACUVUE® OASYS MAX 1-Day MULTIFOCAL

Join Our 40,000+ Community of Eye Health Professionals

Register for JNJVISIONPRO account to receive exclusive access to latest product updates, events, and more.


*T2B descriptive summaries: n ≥ 144

#Versus Dailies Total1®, My Day® and InfuseTM, also significantly lower versus ACUVUE® OASYS 1-Day.

$Filtering of HEV light by contact lenses has not been demonstrated to confer any health benefit to the user, including but not limited to retinal protection, protection from cataract progression, reduced eye strain, improved contrast, improved acuity, reduced glare, improved low light vision, or improved circadian rhythm/sleep cycle. The Eye Care Professional should be consulted for more information.

+Versus publicly available information for standard daily use contact lenses as of December 2023.

†Vertical heterophoria possibly caused by prism dissociation due to the presence of induced optical prism is a relevant factor for practitioners to consider when fitting toric contact lenses for monocular astigmats or those requiring a mix of toric soft contact lens designs e.g., mixed prescriptions.13,14 Clinical studies have not been done to fully characterize the clinical effects of differences in base down prism among different contact lenses.”

References

  1. JJV Data on File 2024, First and Only Daily Disposable Multifocal Toric Contact Lens in US
  2. JJV Data on file, 2024: Subjective Standalone Claims for ACUVUE® OASYS MAX 1-Day MULTIFOCAL Contact Lenses for ASTIGMATISM
  3. JJV Data on file, 2024. Subjective Comparative and Descriptive Standalone Claims for ACUVUE® OASYS MAX 1-Day Contact Lenses for ASTIGMATISM.
  4. COVID-19: Screen Time spikes to over 13 hours per day according to Eyesafe Nielson estimates, published 3/28/20, https://eyesafe.com/covid-19-screen-time-spike-to-over-13-hours-per-day/
  5. JJV Data on File 2022. Blue-Violet Filter Utilized in ACUVUE® OASYS MAX 1-Day contact lenses.
  6. Tsubota K, Nakamori K. Dry eyes and video display terminals. N Engl J Med. 1993;328(8):584. doi: 10.1056/NEJM199302253280817.
  7. Patel S, Henderson R, Bradley L, et al. Effect of visual display unit use on blink rate and tear stability. Optom Vis Sci 1991;68(11):888-892. doi: 10.1097/00006324-199111000-00010.
  8. JJV Data on File 2022. TearStable Technology Definition.
  9. JJV Data on File 2022. Effect on Tear Film and Evaluation of Visual Artifacts of ACUVUE® OASYS MAX 1-Day Family with TearStable Technology.
  10. JJV Data on File 2022. Material Properties: 1-DAY ACUVUE® MOIST, 1-DAY ACUVUE® TruEye®, ACUVUE® OASYS 1-Day with HydraLuxe® Technology and ACUVUE® OASYS MAX 1-Day with TearStable Technology Brand Contact Lenses and other daily disposable contact lens brands.
  11. JJV Data on File: Technical Description of ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM
  12. Data on file 2024, ACUVUE® Brand Contact Lenses for ASTIGMATISM overall fitting success, orientation position, rotational stability and vision performance.
  13. Jackson D et al. Vertical heterophoria and susceptibility to visually induced motion sickness. Strabismus. 2012;20(1):17-23.
  14. Du Toit R et al. Tolerance to prism induced by readymade spectacles: setting and using a standard. OVS 2007;84(11):1053-9.

2025PP09750
Johnson & Johnson MedTech
We support the AdvaMed Code of Ethics on interacting with Healthcare Professionals.
Advamed Logo
© Johnson & Johnson and its affiliates 2024. All rights reserved. This site is published by Johnson & Johnson Vision Care, Inc. and Johnson & Johnson Surgical Vision, Inc., which are solely responsible for its content.

Third party trademarks used herein are trademarks of their respective owners.

Vision Made Possible